Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders

[1] Ray M(2010)The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals AIDS 24 123-137

[2] Logan R(2013)Achieving an AIDS-free world: science and implementation Lancet 382 1461-1462

[3] Sterne JA(1998)Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 853-860

[4] Hernandez-Diaz S(1998)A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 F51-F58

[5] Robins JM(2001)Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor J Acquir Immune Defic Syndr 27 443-449

[6] Fauci AS(2001)Clinical assessment of HIV-associated lipodystrophy in an ambulatory population AIDS 15 1389-1398

[7] Marston HD(2003)An objective case definition of lipodystrophy in HIV-infected adults: a case–control study Lancet 361 726-735

[8] Palella FJ(2003)An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score J Acquir Immune Defic Syndr 33 571-576

[9] Delaney KM(2013)HIV-associated lipodystrophy: impact of antiretroviral therapy Drugs 73 1431-1450

[10] Moorman AC(2013)Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction PLoS One 8 e63623-427

[1] Ray M(2010)The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals AIDS 24 123-137

[2] Logan R(2013)Achieving an AIDS-free world: science and implementation Lancet 382 1461-1462

[3] Sterne JA(1998)Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 853-860

[4] Hernandez-Diaz S(1998)A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 F51-F58

[5] Robins JM(2001)Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor J Acquir Immune Defic Syndr 27 443-449

[6] Fauci AS(2001)Clinical assessment of HIV-associated lipodystrophy in an ambulatory population AIDS 15 1389-1398

[7] Marston HD(2003)An objective case definition of lipodystrophy in HIV-infected adults: a case–control study Lancet 361 726-735

[8] Palella FJ(2003)An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score J Acquir Immune Defic Syndr 33 571-576

[9] Delaney KM(2013)HIV-associated lipodystrophy: impact of antiretroviral therapy Drugs 73 1431-1450

[10] Moorman AC(2013)Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction PLoS One 8 e63623-427